CpG Methylation Changes within the IL2RA Promoter in Type 1 Diabetes of Childhood Onset

被引:31
|
作者
Belot, Marie-Pierre [1 ,2 ]
Fradin, Delphine [1 ,2 ]
Mai, Nga [1 ,2 ]
Le Fur, Sophie [1 ,2 ]
Zelenika, Diana [3 ]
Kerr-Conte, Julie [4 ,5 ]
Pattou, Francois [4 ,5 ]
Lucas, Bruno [6 ]
Bougneres, Pierre [1 ,2 ]
机构
[1] Univ Paris Sud, Bicetre Hosp, Pole I3E, INSERM U986, Paris, France
[2] Univ Paris Sud, Bicetre Hosp, Pole I3E, Dept Pediat Endocrinol, Paris, France
[3] Ctr Natl Genotypage, Evry, France
[4] Univ Lille Nord France, INSERM U859, Lille, France
[5] Ctr Hosp Reg Univ Lille, Lille, France
[6] Cochin Hosp, CNRS Unite Mixte Rech 8104, INSERM U1016, Paris, France
来源
PLOS ONE | 2013年 / 8卷 / 07期
关键词
GENOME-WIDE ASSOCIATION; TROPHOBLAST STEM-CELLS; NATURAL-KILLER-CELLS; HUMAN B-CELLS; DNA METHYLATION; GENE-EXPRESSION; T-CELLS; EPIGENETIC CONTROL; DENDRITIC CELLS; EMBRYONIC STEM;
D O I
10.1371/journal.pone.0068093
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
None of the polymorphic variants of the IL2RA gene found associated with Type 1 Diabetes (T1D) was shown to have a functional effect. To test if the epigenetic variation could play a role at this locus, we studied the methylation of 6 CpGs located within the proximal promoter of IL2RA gene in 252 T1D patients compared with 286 age-matched controls. We found that DNA methylation at CpGs -373 and -456 was slightly but significantly higher in patients than in controls (40.4 +/- 4.6 vs 38.3 +/- 5.4, p = 1.4E4; 91.4 +/- 2.8 vs 89.5 +/- 5.3, p = 1.8E-6), while other CpG showed a strictly comparable methylation. Among 106 single nucleotide polymorphisms (SNPs) located in the neighboring 180kb region, we found that 28 SNPs were associated with DNA methylation at CpG -373. Sixteen of these SNPs were known to be associated with T1D. Our findings suggest that the effect of IL2RA risk alleles on T1D may be partially mediated through epigenetic changes.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Lack of association between methylation status of CpG in the MCP-1 promoter and type 2 diabetes mellitus and its complications in a Moroccan population
    El Alami, Houda
    Ghazal, Hassan
    Abidi, Omar
    Al Idrissi, Najib
    Allali, Malika
    Wakrim, Lahcen
    Naamane, Abderrahmane
    Khlil, Naima
    Hamdi, Salsabil
    GENE REPORTS, 2022, 26
  • [32] Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC
    Mishra, Rajashree
    Akerlund, Mikael
    Cousminer, Diana L.
    Ahlqvist, Emma
    Bradfield, Jonathan P.
    Chesi, Alessandra
    Hodge, Kenyaita M.
    Guy, Vanessa C.
    Brillon, David J.
    Pratley, Richard E.
    Rickels, Michael R.
    Vella, Adrian
    Ovalle, Fernando
    Harris, Ronald I.
    Melander, Olle
    Varvel, Stephen
    Hakonarson, Hakon
    Froguel, Phillippe
    Lonsdale, John T.
    Mauricio, Didac
    Schloot, Nanette C.
    Khunti, Kamlesh
    Greenbaum, Carla J.
    Yderstraede, Knud B.
    Tuomi, Tiinamaija
    Voight, Benjamin F.
    Schwartz, Stanley
    Boehm, Bernhard O.
    Groop, Leif
    Leslie, Richard David
    Grant, Struan F. A.
    DIABETES CARE, 2020, 43 (02) : 418 - 425
  • [33] Diazoxide treatment at onset in childhood type 1 diabetes
    Bjork, E
    Ortquist, E
    Wallensteen, M
    Ludvigsson, J
    Aman, J
    Johansson, C
    Forsander, G
    Blom, L
    Berglund, L
    Persson, B
    Berne, C
    Karlsson, AF
    DIABETES, 2001, 50 : A90 - A90
  • [34] Mortality in childhood-onset type 1 diabetes
    Dahlquist, G
    Källén, B
    DIABETES CARE, 2005, 28 (10) : 2384 - 2387
  • [35] Type 1 Diabetes-Associated IL2RA Variation Lowers IL-2 Signaling and Contributes to Diminished CD4+CD25+ Regulatory T Cell Function
    Garg, Garima
    Tyler, Jennifer R.
    Yang, Jennie H. M.
    Cutler, Antony J.
    Downes, Kate
    Pekalski, Marcin
    Bell, Gwynneth L.
    Nutland, Sarah
    Peakman, Mark
    Todd, John A.
    Wicker, Linda S.
    Tree, Timothy I. M.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (09): : 4644 - 4653
  • [36] Functional dissection of IL2ra superenhancer revals developmentally regulated and cell type specific elements
    Spolski, Rosanne
    Li, Peng
    Oh, Jangsuk
    Liu, Chengyu
    Ren, Min
    Enomoto, Yutaka
    West, Erin
    Shin, Boyoung
    Rothenberg, Ellen
    Leonard, Warren
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [37] CpG Methylation Status Changes Within the Protein Tyrosine Phosphatase Non-Receptor Type 22 Gene Promoters in Children and Adolescents of Greek Origin with Type 1 Diabetes
    Mouzaki, Konstantina
    Giza, Styliani
    Kotanidou, Eleni P.
    Fragou, Aikaterini
    Taousani, Maria
    Eboriadou-Petikopoulou, Maria
    Tzimagiorgis, Georgios
    Galli-Tsinopoulou, Assimina
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 210 - 211
  • [38] Methylation of Specific CpG Sites in IL-1β and IL1R1 Genes is Affected by Hyperglycaemia in Type 2 Diabetic Patients
    Roshanzamir, Naeimeh
    Hassan-Zadeh, Vahideh
    IMMUNOLOGICAL INVESTIGATIONS, 2020, 49 (03) : 287 - 298
  • [39] Deployment of a predictive model based on CpG methylation haplotypes analysis on the insulin gene promoter, in a cohort of children and adolescents with type 1 diabetes
    Kotanidou, Eleni P.
    Mouzaki, Konstantina
    Chouvarda, Ioanna
    Koutsiana, Elisavet
    Kosvyra, Alexandra
    Giza, Styliani
    Galli-Tsinopoulou, Assimina
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 41 - 41
  • [40] DNA methylation changes influence type 2 diabetes
    Carless, M. A.
    Kulkarni, H.
    Mahaney, M. C.
    Goering, H. H. H.
    Curran, J. E.
    Almasy, L.
    Comuzzie, A. G.
    Blangero, J.
    DIABETOLOGIA, 2013, 56 : S61 - S61